[{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Dr. Reddy's Laboratories","pharmaFlowCategory":"D","therapeuticArea":"Nutrition and Weight Loss","country":"SWITZERLAND","productType":"Other Small Molecule","year":"2024","type":"Agreement","leadProduct":"Biotin","moa":"||Krebs cycle activatior","graph1":"Nutrition and Weight Loss","graph2":"Approved FDF","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Nestle Health Sciences SA \/ Dr. Reddy's Laboratories","highestDevelopmentStatusID":"15","companyTruncated":"Nestle Health Sciences SA \/ Dr. Reddy's Laboratories"},{"orgOrder":0,"company":"MedDay Pharmaceuticals","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"FRANCE","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Neurology","graph2":"Phase III","graph3":"MedDay Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"MedDay Pharmaceuticals \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"MedDay Pharmaceuticals \/ Inapplicable"},{"orgOrder":0,"company":"Vestige Marketing","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"INDIA","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Dermatology","graph2":"Approved FDF","graph3":"Vestige Marketing","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vestige Marketing \/ Inapplicable","highestDevelopmentStatusID":"15","companyTruncated":"Vestige Marketing \/ Inapplicable"},{"orgOrder":0,"company":"NovoBliss Research","sponsor":"Orgenetics, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Rare Diseases and Disorders","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Rare Diseases and Disorders","graph2":"Undisclosed","graph3":"NovoBliss Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NovoBliss Research \/ Orgenetics, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"NovoBliss Research \/ Orgenetics, Inc."},{"orgOrder":0,"company":"Nutrition 21, Inc.","sponsor":"ALS Beauty and Personal Care","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutrition 21, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutrition 21, Inc. \/ ALS Beauty and Personal Care","highestDevelopmentStatusID":"1","companyTruncated":"Nutrition 21, Inc. \/ ALS Beauty and Personal Care"},{"orgOrder":0,"company":"Nutra Harmony LLC","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"","productType":"Other Small Molecule","year":"2024","type":"Inapplicable","leadProduct":"Biotin","moa":"Krebs cycle activatior","graph1":"Dermatology","graph2":"Undisclosed","graph3":"Nutra Harmony LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutra Harmony LLC \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Nutra Harmony LLC \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals for (+)-Biotin

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Nutra Harmony LLC

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Nutra Harmony LLC

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 20, 2024

                          Lead Product(s) : Biotin

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Coatings Trends
                          Not Confirmed
                          Coatings Trends
                          Not Confirmed

                          Details : Vestige Prime Absorvit (biotin) is a water-soluble B vitamin that plays a crucial role in various metabolic processes in the body. It is indicated for hair loss.

                          Product Name : Vestige Prime Absorvit

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 10, 2024

                          Lead Product(s) : Biotin

                          Therapeutic Area : Dermatology

                          Highest Development Status : Approved FDF

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Coatings Trends
                          Not Confirmed
                          Coatings Trends
                          Not Confirmed

                          Details : The two companies will establish a joint venture (JV Company) to introduce innovative nutraceutical brands to consumers, with Nestlé licensing brands like Nature's Bounty, an approved nutritional supplement.

                          Product Name : Nature’s Bounty

                          Product Type : Other Small Molecule

                          Upfront Cash : Undisclosed

                          April 25, 2024

                          Lead Product(s) : Biotin,Keratin

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Approved FDF

                          Sponsor : Dr. Reddy\'s Laboratories

                          Deal Size : Undisclosed

                          Deal Type : Agreement

                          blank

                          04

                          Nutrition 21, Inc.

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Nutrition 21, Inc.

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 25, 2023

                          Lead Product(s) : Biotin

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : ALS Beauty and Personal Care

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          NovoBliss Research

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          NovoBliss Research

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 02, 2023

                          Lead Product(s) : Biotin

                          Therapeutic Area : Rare Diseases and Disorders

                          Highest Development Status : Undisclosed

                          Sponsor : Orgenetics, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Coatings Trends
                          Not Confirmed
                          Coatings Trends
                          Not Confirmed

                          Details : SPI2 was designed to confirm the results of the first positive Phase III study, MS-SPI, in progressive multiple sclerosis (MS).

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          October 03, 2020

                          Lead Product(s) : Biotin

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          SPD Development Company Limited

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          SPD Development Company Limited

                          Country arrow
                          Coatings Trends
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          November 20, 2018

                          Lead Product(s) : Biotin

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank